Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity

Oral Oncology

Volumn 43, Issue 8, 2007, Pages 796-803

  Kunkel, Martin ^a   Moergel, Maximilian ^a   Stockinger, Marcus ^a   Jeong, Jong Hyeon ^b   Fritz, Gerhardt ^c   Lehr, Hans Anton ^d   Whiteside, Theresa L ^e  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

^d UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Glucose transporter; GLUT 1; Head and neck cancer; Radiation; Radiation resistance

Indexed keywords

GLUCOSE TRANSPORTER 1;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RADIATION RESPONSE; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PROGNOSIS; RADIATION TOLERANCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 34547963047     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.10.009     Document Type: Article

References (32)

1. Warburg O. Über den Stoffwechsel der Carcinom-Zelle. Klinische Wochenschrift 4 (1925) 534-536
2. Younes M., Brown R.W., Stephenson M., Gondo M., and Cagle P.T. Overexpression of Glut1 and Glut3 in stage I non small cell lung carcinoma is associated with poor survival. Cancer 80 (1997) 1046-1051
3. Haber R.S., Rathan A., Weiser K.R., et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 83 (1998) 34-40
4. Cantuaria G., Fagotti A., Ferrandina G., et al. Glut-1 expression in ovarian carcinoma. Association with survival and response to chemotherapy. Cancer 92 (2001) 1144-1150
5. Kawamura T., Kusakabe T., Sugino T., et al. Expression of glucose transporter 1 in human gastric carcinoma. Association with tumor aggressiveness, metastasis and patient survival. Cancer 92 (2001) 634-641
6. Airley R., Loncaster J., Davidson S., et al. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 7 (2001) 928-934
7. Kunkel M., Reichert T.E., Benz P., et al. Overexpression of Glut-1 and increased glucose metabolism in the tumor are associated with poor prognosis in oral squamous cell carcinoma. Cancer 97 (2003) 1015-1024
8. Oliver R.J., Woodwards R.T.M., Sloan P., Thakker N.S., Stratford I.J., and Airley R.E. Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinoma treated by surgical resection: results of EORTC translational research fund studies. Eur J Cancer 40 (2004) 503-507
9. Airley R.E., Loncaster J., Raleigh J.A., et al. Glut-1 and CAIX as intrinsic markers of hypoxia in carcioma of the cervix: relationship to pimonidazole binding. Int J Cancer 104 (2003) 85-91
10. Flier J.S., Mueckler M.M., Usher P., and Lodish H.F. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235 (1987) 1492-1495
11. Pedersen M.W., Holm S., Lund E.L., Hojgaard L., and Kristjansen P.E. Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in vivo and in vitro. Neoplasia 3 (2001) 80-87
12. Hammermann P.S., Fox C.J., and Thompson C.B. Beginnings of a signal-transduction pathway for bioenegetic control of cell survival. Trends Biochem Sci 11 (2004) 586-592
13. Nutt L.K., Margolis S.S., Jensen M., et al. Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of Caspase-2. Cell 123 (2005) 189-193
14. Battifora H. Assessment of antigen damage in immunohistochemistry. The vimentin internal control. Am J Clin Pathol 96 (1991) 669-671
15. Mohr C., Bohndorf W., Gremmel H., et al. Preoperative radiochemotherapy and radical surgery of advanced head and neck cancers - results of a prospective, multicenter DOSAK study. Recent Res Cancer 134 (1994) 155-163
16. Wittekind C., and Wagner G. TNM-Klassifikation maligner Tumoren. 5th ed. (1997), Springer, Berlin p. 213
17. Kaplan E.L., and Meier P. Nonparametirc estimator from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
18. Cox D.R. Regression models and life-tables (with discussion). J Roy Stat Soc B 34 (1972) 187-202
19. Hoeckel M., and Vaupel P. Tumor hypoxia: definitions and current clinical, biologic and molecular aspects. J Natl Cancer Inst 93 (2001) 266-276
20. Vaupel P., and Harrison L. Tumor hypoxia: causative factors, compensatory mechanisms and cellular response. Oncologist 9 (2004) 4-9
21. Janssen H.L., Haustermans K.M., Balm A.J., and Begg A.C. Hypoxia in head and neck cancer: How much, how important. Head Neck 27 (2005) 622-638
22. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Hypoxia inducible factor (HIF1A and HIF2A), angiogenesis and chemoradiotherapy outcome of squamous cell head and neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 1192-1202
23. Aebersol D.M., Burri P., Beer K.T., et al. Expression of hypoxia inducible factor-1-alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61 (2001) 2911-2916
24. Hui E.P., Chan A.T., Pezella F., et al. Coexpression of hypoxia inducible factors 1 alpha and 2 alpha, carbonic anhydrase IX and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res 8 (2002) 2595-2604
25. Koukourakis M.I., Bentzen S.M., Giatromanolaki A., et al. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 24 (2006) 727-735
26. Mayer A., Wree A., Höckel M., Lea C., Pilch H., and Vaupel P. Lack of correlation between expression of HIF-1α protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res 64 (2004) 5876-5881
27. Mayer A., Höckel M., Wree A., and Vaupel P. Micro regional expression of glucose transporter 1 and oxygenation status: lack of correlation in locally advanced cervical cancers. Clin Cancer Res 11 (2005) 2768-2773
28. Chen C., Pore N., Behrooz A., Ismail-Beigi F., and Maity A. Regulation of glut-1 mRNA by hypoxia-inducible factor-1. J Biol Chem 276 (2001) 9519-9525
29. Elstrom R., Bauer D., Buzzai M., et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64 (2004) 3892-3899
30. Brosius III F.C. How glucose and glucose transporters protect cardiac myocytes. J Mol Cell Cardiol 35 (2003) 1187-1189
31. Moley K.H., and Mueckler M.M. Glucose transport and apoptosis. Apoptosis 5 (2000) 99-105
32. Belka C., Jendrossek V., Prutschy M., Vink S., Verheij M., and Budach W. Apoptosis-modulating agents in combination with radiotherapy - current status and outlook. Int J Radiat Oncol Biol Phys 58 (2004) 542-554